Zippin Bio was founded to address a fundamental challenge in therapeutic development: delivery. Many promissing therapies are often limited by biological barriers that prevent them from reaching target tissues.

Built at the intersection of chemistry, biology, and translational science, Zippin Bio focuses on developing delivery technologies that aim to expand access across protected biological environments, including the central nervous system.